We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Prenetics Global Ltd (PRE) USD0.0001

Sell:$4.68 Buy:$6.20 Change: $0.0461 (0.79%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Sell:$4.68
Buy:$6.20
Change: $0.0461 (0.79%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Sell:$4.68
Buy:$6.20
Change: $0.0461 (0.79%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Prenetics Global Ltd is a company mainly engaged in the diagnostics and genetic testing business. The Company operates its business through two segments. The Diagnostics segment is engaged in the provision of COVID-19 testing services and operation testing laboratories. The Segment is also engaged in the development of health monitoring systems. The Prevention segment is engaged in the provision of genetics testing services to individuals and corporate entities.

Contact details

Address:
7/F, K11 Atelier, 728 King's Road

000000
Hong Kong
Telephone:
+852 () 22109588
Website:
https://ir.prenetics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PRE
ISIN:
KYG722451229
Market cap:
$72.94 million
Shares in issue:
10.64 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
Cayman Islands
Currency:
US dollar
Indices:
n/a

Key personnel

  • Sheng Wu Yeung
    Chairman of the Board, Chief Executive Officer
  • Hoi Chun Lo
    Chief Financial Officer
  • Avrom Lasarow
    Chief Executive Officer of EMEA
  • Yung Ho Wong
    Chief Technology Officer
  • Chi Hung Tzang
    Chief Scientific Officer
  • Wu Po Ma
    Chief R&D Officer
  • Shih-Chang Ong
    Chief Medical Officer
  • Senthil Sundaram
    Chief Clinical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.